Recently, Henlius has achieved the upgraded certification of ISO/IEC 27001:2022 for its Information Security Management System (ISMS), endorsed by CNAS (China National Accreditation Service for Conformity Assessment), ANAB (ANSI National Accreditation Board, USA), and UKAS (United Kingdom Accreditation Service). This certification upgrade signifies that Henlius’ information security management system now fully meets the latest international standards, reaffirming its recognition by global authorities and strengthening the information security foundation that safeguards its globalization strategy.

Jointly developed by the International Organization for Standardization (ISO) and the International Electrotechnical Commission (IEC), ISO/IEC 27001 is the world’s most recognized standard for information security governance. The 2022 edition of the standard centers on information security, cybersecurity, and privacy protection, introducing streamlined and structured control measures alongside new requirements in cutting-edge areas such as cloud services and threat intelligence. It aims to help global organizations build more secure and compliant information security systems. Henlius has successfully upgraded its certification from ISO/IEC 27001:2013 to the 2022 version, establishing a comprehensive, multi-layered information security defense network that integrates technical safeguards, process controls, and personnel protection. On the technical front, the company has implemented multi-level defense mechanisms to enhance system security. In terms of processes, it continues to refine end-to-end controls across cloud service usage, change approvals, and data lifecycle management. From the personnel perspective, Henlius conducts regular training and drills, while leveraging dynamic cyber threat intelligence to comprehensively reduce information security risks.

As a global biopharmaceutical company, Henlius has had six products approved in China and four internationally, reaching over 50 countries and regions across Asia, Europe, Latin America, North America, and Oceania—benefiting over 800,000 patients worldwide. Looking ahead, Henlius will continue to enhance its information security infrastructure to meet the demands of a rapidly digitalizing world and provide comprehensive data-to-trust protection for patients and partners across the globe.